Najib M Rahman1, Brennan C Kahan2, Robert F Miller3, Fergus V Gleeson4, Andrew J Nunn2, Nicholas A Maskell5. 1. Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Oxford University Hospitals NHS Trust, Oxford; Department of Radiology, Oxford University Hospitals, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford; National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford. Electronic address: najib.rahman@ndm.ox.ac.uk. 2. Medical Research Council Clinical Trials Unit. 3. Research Department of Infection and Population Health, Institute of Epidemiology and Healthcare, University College London, London. 4. Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Oxford University Hospitals NHS Trust, Oxford; Department of Radiology, Oxford University Hospitals, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford. 5. Academic Respiratory Unit, School of Clinical Sciences, Southmead Hospital, University of Bristol, Bristol, England.
Abstract
BACKGROUND: Pleural infection is associated with a high morbidity and mortality. Development of a validated clinical risk score at presentation to identify those at high risk of dying would enable patient triage and may help formulate early management strategies. METHODS: A clinical risk score was derived based on data from patients entering the multicenter UK pleural infection trial (first Multicenter Intrapleural Sepsis Trial [MIST1], n=411). From 22 baseline clinical characteristics, model selection was undertaken to find variables predictive of poor clinical outcome. Outcomes were mortality at 3 months (primary), need for surgical intervention at 3 months, and time from randomization to discharge. The derived scoring system RAPID (renal, age, purulence, infection source, and dietary factors) was validated using patients enrolled in the subsequent MIST2 trial (n=191). RESULTS: Age, urea, albumin, hospital-acquired infection, and nonpurulence predicted poor outcome. Patients were stratified into low-risk (0-2), medium-risk (3-4), and high-risk (5-7) groups. Using the low-risk group as a reference, a RAPID score of 3 to 4 and >4 was associated with an OR of 24.4 (95% CI, 3.1-186.7; P=.002) and 192.4 (95% CI, 25.0-1480.4; P<.001), respectively, for death at 3 months. In the validation cohort (MIST2), a medium-risk RAPID score was nonsignificantly associated with mortality (OR, 3.2; 95% CI, 0.8-13.2; P=.11), and a high-risk score was associated with increased mortality (OR, 14.1; 95% CI, 3.5-56.8; P<.001). Hospitalization duration was associated with increasing RAPID score (score 0-2: median duration=7, interquartile range 6-13; score>5: median duration=15, interquartile range 9-28, P=.08). CONCLUSIONS: The RAPID score may permit risk stratification of patients with pleural infection at presentation.
BACKGROUND: Pleural infection is associated with a high morbidity and mortality. Development of a validated clinical risk score at presentation to identify those at high risk of dying would enable patient triage and may help formulate early management strategies. METHODS: A clinical risk score was derived based on data from patients entering the multicenter UK pleural infection trial (first Multicenter Intrapleural Sepsis Trial [MIST1], n=411). From 22 baseline clinical characteristics, model selection was undertaken to find variables predictive of poor clinical outcome. Outcomes were mortality at 3 months (primary), need for surgical intervention at 3 months, and time from randomization to discharge. The derived scoring system RAPID (renal, age, purulence, infection source, and dietary factors) was validated using patients enrolled in the subsequent MIST2 trial (n=191). RESULTS: Age, urea, albumin, hospital-acquired infection, and nonpurulence predicted poor outcome. Patients were stratified into low-risk (0-2), medium-risk (3-4), and high-risk (5-7) groups. Using the low-risk group as a reference, a RAPID score of 3 to 4 and >4 was associated with an OR of 24.4 (95% CI, 3.1-186.7; P=.002) and 192.4 (95% CI, 25.0-1480.4; P<.001), respectively, for death at 3 months. In the validation cohort (MIST2), a medium-risk RAPID score was nonsignificantly associated with mortality (OR, 3.2; 95% CI, 0.8-13.2; P=.11), and a high-risk score was associated with increased mortality (OR, 14.1; 95% CI, 3.5-56.8; P<.001). Hospitalization duration was associated with increasing RAPID score (score 0-2: median duration=7, interquartile range 6-13; score>5: median duration=15, interquartile range 9-28, P=.08). CONCLUSIONS: The RAPID score may permit risk stratification of patients with pleural infection at presentation.
Authors: Rachel M Mercer; John P Corcoran; Jose M Porcel; Najib M Rahman; Ioannis Psallidas Journal: Clin Med (Lond) Date: 2019-05 Impact factor: 2.659
Authors: Sunkaru Touray; Rahul N Sood; Daniel Lindstrom; Jonathan Holdorf; Sumera Ahmad; Daniel B Knox; Andres F Sosa Journal: Lung Date: 2018-08-11 Impact factor: 2.584
Authors: Martin Reichert; Matthias Hecker; Biruta Witte; Johannes Bodner; Winfried Padberg; Markus A Weigand; Andreas Hecker Journal: Langenbecks Arch Surg Date: 2016-11-04 Impact factor: 3.445
Authors: Jason R McClune; Candice L Wilshire; Jed A Gorden; Brian E Louie; Alexander S Farviar; Michael J Stefanski; Eric Vallieres; Ralph W Aye; Christopher R Gilbert Journal: Can Respir J Date: 2016-06-30 Impact factor: 2.409